Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder

The Journal of the American Board of Family Practice
Daniel J CoxBoris Kovatchev

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is associated with a 3- to 4-fold increase in both driving-related accidents and associated injuries. Methylphenidate (MPH) is the most commonly prescribed psychostimulant medication for ADHD. It has been demonstrated to improve performance on a driving simulator. This study investigated whether a once-daily, long-acting, osmotic, controlled-release MPH formulation improves the driving performance of ADHD adolescents while driving their own car on an actual road segment. Twelve ADHD-diagnosed male adolescent drivers (mean age, 17.8 years) prescribed a standard dose of 1.0 mg/kg (if they were not already taking methylphenidate) of controlled-release MPH participated in this repeated-measures crossover study. On 2 separate occasions (off/on medication randomized), participants drove a standard 16-mile road course incorporating rural, highway, and urban streets. A rater, blind to medication conditions, sat in the back seat and rated impulsive (eg, "cutting off" another driver) and inattentive (eg, drove past designated turn) driving errors. Impulsive driving errors were observed to occur rarely under both medication and no medication conditions. Inattentive driving errors were more c...Continue Reading

Citations

Apr 1, 2005·Current Opinion in Pediatrics·Alison Schonwald
Nov 13, 2012·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·Sudha R RamanTil Stürmer
Sep 8, 2006·Behavior Research Methods·Bryan ReimerJoseph Biederman
Oct 16, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·E SobanskiP Strohbeck-Kühner
Mar 3, 2011·Developmental Psychobiology·Lori A Newman, Jill McGaughy
Aug 28, 2010·Journal of Child and Adolescent Psychiatric Nursing : Official Publication of the Association of Child and Adolescent Psychiatric Nurses, Inc·Vanya HamrinVeda Tyson
Jan 31, 2006·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Cynthia L LeibsonSlavica K Katusic
Oct 1, 2015·Journal of Neural Transmission·Anselm B M FuermaierOliver Tucha
Jul 22, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Maria Angela Gobbo, Mario R Louzã
Jul 19, 2005·Lancet·Joseph Biederman, Stephen V Faraone
Jun 11, 2008·Journal of Psychopharmacology·J C Verster, D J Cox
Nov 7, 2006·Journal of Attention Disorders·Daniel J CoxBoris Kovatchev
Jan 24, 2007·Journal of Attention Disorders·Russell A BarkleyMarkus Kruesi
Apr 14, 2012·Journal of Attention Disorders·J J Sandra KooijPaul Hodgkins
Mar 2, 2012·Journal of Attention Disorders·Philip AshersonPaul Hodgkins
Oct 16, 2007·Journal of Attention Disorders·Steven C MarcusMark Olfson
Nov 26, 2015·The Cochrane Database of Systematic Reviews·Ole Jakob StorebøChristian Gluud
Sep 25, 2007·Journal of Psychiatric Practice·David W Goodman
Feb 5, 2008·Pediatric Annals·Richard H Gilchrist, Eugene L Arnold
Mar 15, 2006·Expert Review of Neurotherapeutics·William P Cheshire
Oct 6, 2006·Expert Opinion on Pharmacotherapy·David Coghill, Sarah Seth
Jan 18, 2006·Gan to kagaku ryoho. Cancer & chemotherapy·Hiroya TakiuchiKen-ichi Katsu
Apr 9, 2008·CNS Spectrums·Stephen V Faraone
Jul 13, 2016·Journal of Attention Disorders·Nastassia J S RandellNicola J Starkey
Jan 14, 2011·Expert Opinion on Pharmacotherapy·Keith McBurnett, H Lynn Starr
Oct 1, 2008·Postgraduate Medicine·Kenneth W Steinhoff
Feb 16, 2021·Epidemiology and Psychiatric Sciences·Yi-Chun LiuMichael Gossop
Dec 5, 2006·Pediatrics·Jeffrey C WeissJeffrey C Weiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.